Heralded Alzheimer's Drug Works, but Safety Concerns Loom
Eisai and Biogen share clinical trial data confirming that lecanemab slows mental decline amid reports of potentially related deaths
Eisai and Biogen share clinical trial data confirming that lecanemab slows mental decline amid reports of potentially related deaths